Medical insurance plans and provider organizations are joining together to deliver health care. The article discusses these Payvider collaborations. Read More
Due to the increasing value of chronic kidney disease treatments, this article reviews health plans’ current and potential spending priorities Read More
This article reviews chronic disease management programs and some of the various statistics surround them and their relation to payers and patients. Read More
NephU hosts veteran nephrology editor Mark Neumann to discuss some of the updates finalized in the ESRD PPS rule for 2023, and their implications for providers in the kidney care… Read More
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.